Analytical Data
-
Gene name
FXYD3
- Application
-
Alternative Names
Chloride conductance inducer protein Mat-8 (Mammary tumor 8 kDa protein) (Phospholemman-like) (Sodium/potassium-transporting ATPase subunit FXYD3) ( MAT8) (PLML)
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14802
-
Expression Region
21-38aa
-
Molecular Weight
18.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FXYD3, a member of the FXYD family of proteins, plays a critical role in the regulation of ion transport and membrane potential in various cell types. It is primarily known for its association with Na+/K+ ATPase, influencing its activity and stability, which is vital for maintaining cellular homeostasis. Research into FXYD3 has gained momentum due to its potential implications in several physiological and pathological processes, including cardiac function, neuronal signaling, and cancer progression. Abnormal expression of FXYD3 has been observed in certain malignancies, suggesting a potential role as a biomarker for tumor diagnosis or as a therapeutic target. Recent studies have focused on elucidating the molecular mechanisms through which FXYD3 modulates ion transport and its interaction with other membrane proteins. Understanding the structure and function of FXYD3, particularly through the development of recombinant protein systems, is essential for unveiling its biological significance and exploring its potential in drug development. The growing interest in FXYD3 highlights the need for comprehensive studies to clarify its role in health and disease, paving the way for innovative approaches in treatment strategies.
